Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.

doi:10.1007/s12029-020-00426-8

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.

Journal of gastrointestinal cancer - 1 Jun 2021

Yari Abolfazl, Samoudi Arash, Afzali Asiyeh, Karam Zahra Miri, Karimaldini Negin Khaje, Abadi Maryam Fekri Soofi, Ziasistani Mahsa, Zangouey Mohammad Reza, Dabiri Shahriar

Abstract excerpt

MAIN PURPOSE: This study aimed to determine any association of KRAS and BRAF mutations in colorectal cancer with clinicopathological features and overall survival (OS) of Southeast Iranian colorectal cancer (CRC) patients. METHODS: Overall, KRAS and BRAF status were assessed in 100 Iranian CRC su...

Topics

Adult
Age Factors
Aged
Aged, 80 and over
Biomarkers, Tumor
Cell Differentiation
Colon
Colorectal Neoplasms
DNA Mutational Analysis
Female
Humans
Iran
Kaplan-Meier Estimate
Male
Microsatellite Instability

Source

Open in PubMed

Identifiers

PMID: 32495109
DOI: 10.1007/s12029-020-00426-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-32495109-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Middle Aged

Mutation

Prognosis